Diagnostic and Interventional Cardiology

New phenomapping tool and clinical score could lead to personalized strategies for patients hospitalized with ADHF

Machine Learning Informs a New Tool to Guide Treatment for Acute Decompensated Heart Failure

February 6, 2024 — A recent study co-authored by Dr. Matthew Segar, a third-year cardiovascular disease fellow at The ...

February 06, 2024

ATTRibute-CM results also demonstrated rapid clinical benefit on the composite endpoint of all-cause mortality (ACM) and CVH in patients treated with acoramidis, with time-to-first event Kaplan-Meier curves separating at month 3 and continuing to diverge steadily through Month 30

News | FDA

BridgeBio Pharma Announces U.S. Food and Drug Administration (FDA) Acceptance of New Drug Application (NDA) for Acoramidis for the Treatment of Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

February 6, 2024 — BridgeBio Pharma, Inc., a commercial-stage biopharmaceutical company focused on genetic diseases and ...

February 06, 2024

EGF Mapping system aims to improve patient outcomes by enabling precise and personalized ablation strategies

News | Atrial Fibrillation

Cortex Announces RESOLVE-AF Trial Evaluating Electrographic Flow (EGF) Mapping for use in Atrial Fibrillation Ablation

February 6, 2024 — Cortex announced the initiation of its RESOLVE-AF trial (NCT05883631), a study formally launched in ...

February 06, 2024

Sponsored Content

ASCEND provides the tools that not only address the unique needs of each cardiovascular subspecialty and to care for patients from infancy into their golden years, they also innovates next-generation solutions and services that empower the provider community to truly transform their cardiovascular services

Feature | Information Technology

SPONSORED CONTENT: Unveiling the Future of Cardiovascular Workflow

Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

March 21, 2024

Latest digital platform provides key advancements to help maintain high signal fidelity while reducing environmental noise

News | EP Lab

GE HealthCare Announces Prucka 3 Digital Amplifier as Next Generation Platform for Electrophysiology Innovation

February 2, 2024 — GE HealthCare (Nasdaq: GEHC) announces the latest innovation in electrophysiology (EP), the Prucka 3 ...

February 02, 2024

News | Atrial Fibrillation

Biosense Webster Study Supports Low and Zero Fluoroscopy Workflow as Safe, Effective Alternative to Conventional Catheter Ablation

February 2, 2024 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson ...

February 02, 2024

The American College of Cardiology’s Cardiac Oncology Conference, “Advancing the Cardiovascular Care of the Oncology Patient,” will be held at the Heart House in Washington, D.C., from Feb. 9-11, 2024

News | ACC

American College of Cardiology (ACC) Program Set for Cardiac Oncology Conference, “Advancing the Cardiovascular Care of the Oncology Patient”

February 2, 2024 — The American College of Cardiology’s Cardiac Oncology Conference, “Advancing the Cardiovascular Care ...

February 02, 2024

Sponsored Content

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability to diagnose cardiac disease with greater accuracy and precision

Feature | Cardiac Imaging

SPONSORED CONTENT: Finding the Right Solution

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...

March 05, 2024

The EVOQUE system is indicated for the improvement of health status in patients with symptomatic severe TR despite optimal medical therapy (OMT), for whom tricuspid valve replacement is deemed appropriate by a heart team.

News | FDA

Edwards’ EVOQUE Valve Replacement System First Transcatheter Therapy Earns FDA Approval for Tricuspid Valve

February 2, 2024 — Edwards Lifesciences Corporation announced the company’s EVOQUE tricuspid valve replacement system is ...

February 02, 2024

A new paper in JAMA describes how, despite widespread enthusiasm about AI’s potential and the current use of AI-powered tools, no federal regulations require that AI-powered tools be evaluated for potential harm or benefit to patients

News | Artificial Intelligence

Paper Calls for Patient-first Regulation of AI in Healthcare

February 1, 2024 — Ever wonder if the latest and greatest artificial intelligence (AI) tool you read about in the ...

February 01, 2024

In addressing efficacy, harm, and logistics, the study passes all three of the criteria suggested by the American Heart Association guiding the implementation of polygenic risk scores (PRSs) in cardiovascular care

News | Cardiovascular Clinical Studies

Genomics plc Publishes Clinical Trial Results Demonstrating Successful Integration and Clinical Utility of Integrated Risk Scores Combining Polygenic and Clinical Risk of Cardiovascular Disease in NHS Primary Care

February 1, 2024 — Genomics plc (Genomics), a healthcare company aiming to transform health through the power of ...

February 01, 2024

Sponsored Content

Blog

BLOG: Combining Local Impedance with Contact Force to Perform RF Ablation

When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...

December 11, 2023

As cardiologists, heart disease patients and the organizations that serve them across the country embark on American Heart Month, ITN has compiled a snapshot of significant cardiovascular disease (CVD) and stroke statistics, along with a review of the atherosclerosis drug market.

Feature | Cardiovascular Education | Christine Book

American Heart Month Puts Spotlight on Cardiovascular Disease and Stroke Statistics

February 1, 2024 — As cardiologists, heart disease patients and the organizations that serve them across the country ...

February 01, 2024

Here is a look at the most-read content during the month of January on dicardiology.com

Feature | Cardiovascular Business | By Melinda Taschetta-Millane

Top 10: What Viewers Were Reading in January

It is a new year with lots of new content! Here is a look at the most-read content during the month of January on ...

February 01, 2024

Latest innovation has the potential to reduce anesthesia during minimally invasive procedures

News | Transesophageal Echo (TEE)

New Philips Mini TEE Ultrasound Transducer Helps Improve Cardiac Care for More Patients

January 31, 2024 — Royal Philips, a global leader in health technology, announced that its latest TEE transducer ...

January 31, 2024

Sponsored Content

Case Study | Hemodynamic Monitoring Systems

TECH BRIEF — Integrated Hemodynamic Monitoring System Helps Improve Lab Performance, Efficiency

Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...

November 14, 2023

Outlines methods for interventional cardiologists to identify types of calcified coronary lesions and presents an algorithm to guide the use of calcium modification strategies

News | Angiography

SCAI Publishes Expert Consensus Statement on Management of Calcified Coronary Lesions Requiring Intervention

January 31, 2024 — Coronary artery calcification is increasing in prevalence, leading to greater risks both during ...

January 31, 2024

News | FDA

W. L. Gore Receives FDA Approval for Lower Profile Gore Viabahn VBX Balloon Expandable Endoprosthesis

January 31, 2024 — As part of efforts to continuously improve medical solutions for patients with complex vascular ...

January 31, 2024

The U.S. Food and Drug Administration (FDA), has granted approval to Boston Scientific for its FARAPULSE Pulsed Field Ablation System.

News | FDA

Boston Scientific Receives FDA Approval for FARAPULSE Pulsed Field Ablation System

January 31, 2024 — Boston Scientific Corporation announced it has received U.S. Food and Drug Administration (FDA) ...

January 31, 2024